ABBOTT LABORATORIES (ABL.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:ABL - US0028241000 - Common Stock
106.16 EUR
+1.02 (+0.97%)
ABL gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 64 industry peers in the Health Care Equipment & Supplies industry. ABL scores excellent points on both the profitability and health parts. This is a solid base for a good stock. While showing a medium growth rate, ABL is valued expensive at the moment. These ratings would make ABL suitable for quality investing!
1. Profitability
1.1 Basic Checks
ABL had positive earnings in the past year.
In the past year ABL had a positive cash flow from operations.
In the past 5 years ABL has always been profitable.
ABL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 16.60%, ABL belongs to the best of the industry, outperforming 92.06% of the companies in the same industry.
With an excellent Return On Equity value of 27.43%, ABL belongs to the best of the industry, outperforming 93.65% of the companies in the same industry.
ABL has a Return On Invested Capital of 9.90%. This is in the better half of the industry: ABL outperforms 77.78% of its industry peers.
ABL had an Average Return On Invested Capital over the past 3 years of 10.45%. This is in line with the industry average of 9.81%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROIC | 9.9% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
1.3 Margins
With an excellent Profit Margin value of 31.88%, ABL belongs to the best of the industry, outperforming 98.41% of the companies in the same industry.
ABL's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 18.29%, ABL is in the better half of the industry, outperforming 76.19% of the companies in the same industry.
In the last couple of years the Operating Margin of ABL has grown nicely.
The Gross Margin of ABL (56.19%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ABL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% |
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ABL is creating some value.
Compared to 1 year ago, ABL has about the same amount of shares outstanding.
Compared to 5 years ago, ABL has less shares outstanding
ABL has a better debt/assets ratio than last year.
2.2 Solvency
ABL has an Altman-Z score of 5.67. This indicates that ABL is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ABL (5.67) is better than 88.89% of its industry peers.
ABL has a debt to FCF ratio of 1.87. This is a very positive value and a sign of high solvency as it would only need 1.87 years to pay back of all of its debts.
ABL has a better Debt to FCF ratio (1.87) than 82.54% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that ABL is not too dependend on debt financing.
ABL has a Debt to Equity ratio of 0.23. This is in the better half of the industry: ABL outperforms 68.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Altman-Z | 5.67 |
ROIC/WACC1.17
WACC8.45%
2.3 Liquidity
A Current Ratio of 1.70 indicates that ABL should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.70, ABL is in line with its industry, outperforming 52.38% of the companies in the same industry.
ABL has a Quick Ratio of 1.24. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.24, ABL is in line with its industry, outperforming 58.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
ABL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.40%, which is quite good.
The Earnings Per Share has been growing slightly by 7.59% on average over the past years.
The Revenue has been growing slightly by 6.37% in the past year.
The Revenue has been growing slightly by 5.63% on average over the past years.
EPS 1Y (TTM)10.4%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%7.44%
Revenue 1Y (TTM)6.37%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%6.9%
3.2 Future
The Earnings Per Share is expected to grow by 9.89% on average over the next years. This is quite good.
ABL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.22% yearly.
EPS Next Y11.44%
EPS Next 2Y10.8%
EPS Next 3Y10.58%
EPS Next 5Y9.89%
Revenue Next Year6.44%
Revenue Next 2Y7.19%
Revenue Next 3Y7.32%
Revenue Next 5Y7.22%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 24.92 indicates a rather expensive valuation of ABL.
Based on the Price/Earnings ratio, ABL is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
ABL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.54, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 21.69, ABL is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ABL is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of ABL to the average of the S&P500 Index (23.78), we can say ABL is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.92 | ||
| Fwd PE | 21.69 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ABL is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, ABL is valued a bit cheaper than the industry average as 65.08% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 31.26 | ||
| EV/EBITDA | 19.65 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ABL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.18
PEG (5Y)3.29
EPS Next 2Y10.8%
EPS Next 3Y10.58%
5. Dividend
5.1 Amount
ABL has a Yearly Dividend Yield of 1.91%. Purely for dividend investing, there may be better candidates out there.
ABL's Dividend Yield is a higher than the industry average which is at 1.24.
Compared to an average S&P500 Dividend Yield of 1.96, ABL has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.91% |
5.2 History
On average, the dividend of ABL grows each year by 11.40%, which is quite nice.
Dividend Growth(5Y)11.4%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
28.93% of the earnings are spent on dividend by ABL. This is a low number and sustainable payout ratio.
ABL's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.93%
EPS Next 2Y10.8%
EPS Next 3Y10.58%
FRA:ABL (12/12/2025, 7:00:00 PM)
106.16
+1.02 (+0.97%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners81.17%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap184.60B
Revenue(TTM)43.84B
Net Income(TTM)13.98B
Analysts79.43
Price Target124.8 (17.56%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.91% |
Yearly Dividend1.89
Dividend Growth(5Y)11.4%
DP28.93%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.82%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.58%
EPS beat(4)1
Avg EPS beat(4)-0.52%
Min EPS beat(4)-1.16%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.07%
EPS beat(12)7
Avg EPS beat(12)1.63%
EPS beat(16)11
Avg EPS beat(16)5.69%
Revenue beat(2)0
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-1.08%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-0.75%
Revenue beat(12)4
Avg Revenue beat(12)0.15%
Revenue beat(16)8
Avg Revenue beat(16)1.85%
PT rev (1m)-1.38%
PT rev (3m)0.94%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.48%
EPS NY rev (1m)0%
EPS NY rev (3m)0.15%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)0.1%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-0.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.92 | ||
| Fwd PE | 21.69 | ||
| P/S | 4.93 | ||
| P/FCF | 31.26 | ||
| P/OCF | 23.71 | ||
| P/B | 4.24 | ||
| P/tB | 10.11 | ||
| EV/EBITDA | 19.65 |
EPS(TTM)4.26
EY4.01%
EPS(NY)4.89
Fwd EY4.61%
FCF(TTM)3.4
FCFY3.2%
OCF(TTM)4.48
OCFY4.22%
SpS21.52
BVpS25.02
TBVpS10.5
PEG (NY)2.18
PEG (5Y)3.29
Graham Number48.97
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROCE | 11.52% | ||
| ROIC | 9.9% | ||
| ROICexc | 11.13% | ||
| ROICexgc | 21.33% | ||
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% | ||
| FCFM | 15.78% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
ROICexc(3y)12.18%
ROICexc(5y)11.89%
ROICexgc(3y)32.65%
ROICexgc(5y)35.03%
ROCE(3y)12.16%
ROCE(5y)11.86%
ROICexgc growth 3Y-24.08%
ROICexgc growth 5Y-8.19%
ROICexc growth 3Y-10.71%
ROICexc growth 5Y6.04%
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
F-Score7
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Debt/EBITDA | 1.04 | ||
| Cap/Depr | 70.33% | ||
| Cap/Sales | 5.02% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.77% | ||
| Profit Quality | 49.49% | ||
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 5.67 |
F-Score7
WACC8.45%
ROIC/WACC1.17
Cap/Depr(3y)63.63%
Cap/Depr(5y)61.92%
Cap/Sales(3y)4.94%
Cap/Sales(5y)5.1%
Profit Quality(3y)82.78%
Profit Quality(5y)99.6%
High Growth Momentum
Growth
EPS 1Y (TTM)10.4%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%7.44%
EPS Next Y11.44%
EPS Next 2Y10.8%
EPS Next 3Y10.58%
EPS Next 5Y9.89%
Revenue 1Y (TTM)6.37%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%6.9%
Revenue Next Year6.44%
Revenue Next 2Y7.19%
Revenue Next 3Y7.32%
Revenue Next 5Y7.22%
EBIT growth 1Y15.18%
EBIT growth 3Y-6.62%
EBIT growth 5Y8.41%
EBIT Next Year27.08%
EBIT Next 3Y15.42%
EBIT Next 5Y13.66%
FCF growth 1Y53.98%
FCF growth 3Y-9.78%
FCF growth 5Y7.14%
OCF growth 1Y39.24%
OCF growth 3Y-6.69%
OCF growth 5Y6.88%
ABBOTT LABORATORIES / ABL.DE FAQ
What is the fundamental rating for ABL stock?
ChartMill assigns a fundamental rating of 6 / 10 to ABL.DE.
What is the valuation status for ABL stock?
ChartMill assigns a valuation rating of 3 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Overvalued.
What is the profitability of ABL stock?
ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 7 / 10.
What are the PE and PB ratios of ABBOTT LABORATORIES (ABL.DE) stock?
The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABL.DE) is 24.92 and the Price/Book (PB) ratio is 4.24.
Can you provide the financial health for ABL stock?
The financial health rating of ABBOTT LABORATORIES (ABL.DE) is 7 / 10.